Search research articles
Contact Us
Filters
Showing results (501-510 of 545) with videos related to
Page
of 55
Sort By:
Journal of Medicinal Chemistry
|
March 13, 2024
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression
Zhixiang Chen, Mi Wang, Dimin Wu, et al.
Neuroscience Bulletin
|
March 2, 2022
Pathological Networks Involving Dysmorphic Neurons in Type II Focal Cortical Dysplasia
Yijie Shao, Qianqian Ge, Jiachao Yang, et al.
Journal of Medicinal Chemistry
|
March 26, 2024
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
Zhixiang Chen, Mi Wang, Dimin Wu, et al.
Journal of Affective Disorders
|
March 2, 2023
The percentage of cognitive impairment in patients with major depressive disorder over the course of the depression: A longitudinal study
Jin Liu, Yanjun Chen, Xinyu Xie, et al.
Plos One
|
September 21, 2017
Genetic and phenotypic effects of chromosome segments introgressed from Gossypium barbadense into Gossypium hirsutum
Weiwu Song, Mi Wang, Wei Su, et al.
Journal of Medicinal Chemistry
|
September 23, 2024
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
Atsunori Kaneshige, Yiqing Yang, Longchuan Bai, et al.
Psychiatry Research
|
August 14, 2023
The longitudinal change pattern of cognitive subtypes in medication-free patients with major depressive disorder: a cluster analysis
Weilong Guo, Bangshan Liu, Xiyu Wei, et al.
Nature Chemical Biology
|
February 2, 2023
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
Atsunori Kaneshige, Longchuan Bai, Mi Wang, et al.
Journal of Affective Disorders
|
June 21, 2020
Connectome-based models can predict early symptom improvement in major depressive disorder
Yumeng Ju, Corey Horien, Wentao Chen, et al.
Journal of Medicinal Chemistry
|
November 7, 2024
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
Renqi Xu, Haibin Zhou, Longchuan Bai, et al.
Page
of 55
Search research articles
Search
Showing results (501-510 of 545) with videos related to
Sort By:
Page
of 55
Journal of Medicinal Chemistry
|
March 13, 2024
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression
Zhixiang Chen, Mi Wang, Dimin Wu, et al.
Neuroscience Bulletin
|
March 2, 2022
Pathological Networks Involving Dysmorphic Neurons in Type II Focal Cortical Dysplasia
Yijie Shao, Qianqian Ge, Jiachao Yang, et al.
Journal of Medicinal Chemistry
|
March 26, 2024
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
Zhixiang Chen, Mi Wang, Dimin Wu, et al.
Journal of Affective Disorders
|
March 2, 2023
The percentage of cognitive impairment in patients with major depressive disorder over the course of the depression: A longitudinal study
Jin Liu, Yanjun Chen, Xinyu Xie, et al.
Plos One
|
September 21, 2017
Genetic and phenotypic effects of chromosome segments introgressed from Gossypium barbadense into Gossypium hirsutum
Weiwu Song, Mi Wang, Wei Su, et al.
Journal of Medicinal Chemistry
|
September 23, 2024
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
Atsunori Kaneshige, Yiqing Yang, Longchuan Bai, et al.
Psychiatry Research
|
August 14, 2023
The longitudinal change pattern of cognitive subtypes in medication-free patients with major depressive disorder: a cluster analysis
Weilong Guo, Bangshan Liu, Xiyu Wei, et al.
Nature Chemical Biology
|
February 2, 2023
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
Atsunori Kaneshige, Longchuan Bai, Mi Wang, et al.
Journal of Affective Disorders
|
June 21, 2020
Connectome-based models can predict early symptom improvement in major depressive disorder
Yumeng Ju, Corey Horien, Wentao Chen, et al.
Journal of Medicinal Chemistry
|
November 7, 2024
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
Renqi Xu, Haibin Zhou, Longchuan Bai, et al.
Page
of 55